DEPOCYT vs INFUGEM

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 11, 2026·How we rate

Possible drug interaction. DEPOCYT and INFUGEM are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DEPOCYT	INFUGEM
Rating	70/100	New
Pharmacy pays	—	~$599.88 /30
Type	RX	RX
Active ingredient	CYTARABINE	GEMCITABINE HYDROCHLORIDE
Manufacturer	Pacira Pharms Inc	Sun Pharm
Dosage forms	Injectable, Liposomal	Solution
Drug class	Nucleoside Metabolic Inhibitor	Nucleoside Metabolic Inhibitor
Boxed warning	None	None
Treats	Leukemia, Lymphoma, Meningeal Neoplasms	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms

depocyt infugem

Rating

70/100

New

Pharmacy pays

—

~$599.88 /30

Type

Active ingredient

CYTARABINE

GEMCITABINE HYDROCHLORIDE

Manufacturer

Pacira Pharms Inc

Sun Pharm

Dosage forms

Injectable, Liposomal

Solution

Drug class

Nucleoside Metabolic Inhibitor

Boxed warning

None

Treats

Leukemia, Lymphoma, Meningeal Neoplasms

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms

Frequently asked questions

What is the difference between Depocyt and Infugem?

Depocyt contains Cytarabine, while Infugem contains Gemcitabine Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.